Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics

Published:2019-12 Issue: Volume:238 Page:116963
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Ou-Yang Fu,Pan Mei-Ren,Chang Shu-Jyuan,Wu Chun-Chieh,Fang Shao-Yu,Li Chung-Liang,Hou Ming-Feng,Luo Chi-Wen

Funder

Kaohsiung Medical University Hospital

Ministry of Health and Welfare, Taiwan

KMU-KMUH

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Biological subtypes of breast cancer: prognostic and therapeutic implications;Yersal;World J. Clin. Oncol.,2014

3. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways;Eroles;Cancer Treat Rev.,2012

4. Therapeutic targets in triple negative breast cancer;O'Toole;J. Clin. Pathol.,2013

5. Molecular stratification of triple-negative breast cancers;Perou;The Oncologist,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex Expression in Endometrial Carcinoma;Anticancer Research;2024-03-27

2. CHROMO domain readers: A rainbow of opportunities;Chromatin Readers in Health and Disease;2024

3. Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer;Biomedicine & Pharmacotherapy;2023-07

4. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer;Journal of Translational Medicine;2023-01-21

5. CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma;Pathology - Research and Practice;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3